nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1H—myometrium—ovarian cancer	0.011	0.0738	CbGeAlD
Isradipine—CACNA1C—myometrium—ovarian cancer	0.00838	0.0562	CbGeAlD
Isradipine—CACNA1H—gonad—ovarian cancer	0.00718	0.0482	CbGeAlD
Isradipine—CACNA2D2—vagina—ovarian cancer	0.00715	0.048	CbGeAlD
Isradipine—CACNA1H—uterus—ovarian cancer	0.00713	0.0479	CbGeAlD
Isradipine—CACNA1D—uterine cervix—ovarian cancer	0.00706	0.0474	CbGeAlD
Isradipine—CACNA1H—female reproductive system—ovarian cancer	0.00641	0.043	CbGeAlD
Isradipine—CACNA2D2—testis—ovarian cancer	0.00638	0.0428	CbGeAlD
Isradipine—CACNA1C—decidua—ovarian cancer	0.00621	0.0417	CbGeAlD
Isradipine—CACNA1H—female gonad—ovarian cancer	0.00583	0.0391	CbGeAlD
Isradipine—CACNB2—vagina—ovarian cancer	0.00548	0.0367	CbGeAlD
Isradipine—CACNA2D1—bone marrow—ovarian cancer	0.00537	0.036	CbGeAlD
Isradipine—CACNA1H—testis—ovarian cancer	0.00517	0.0347	CbGeAlD
Isradipine—CACNA2D1—female gonad—ovarian cancer	0.00517	0.0347	CbGeAlD
Isradipine—CACNA2D1—vagina—ovarian cancer	0.00514	0.0345	CbGeAlD
Isradipine—CACNB2—testis—ovarian cancer	0.00489	0.0328	CbGeAlD
Isradipine—CACNA1C—female reproductive system—ovarian cancer	0.00489	0.0328	CbGeAlD
Isradipine—CACNA2D2—lymph node—ovarian cancer	0.00462	0.031	CbGeAlD
Isradipine—CACNA2D1—testis—ovarian cancer	0.00459	0.0308	CbGeAlD
Isradipine—CACNA1C—vagina—ovarian cancer	0.00442	0.0296	CbGeAlD
Isradipine—CACNA1D—testis—ovarian cancer	0.00427	0.0287	CbGeAlD
Isradipine—CACNA1C—testis—ovarian cancer	0.00394	0.0265	CbGeAlD
Isradipine—CACNA1H—lymph node—ovarian cancer	0.00375	0.0252	CbGeAlD
Isradipine—CACNB2—lymph node—ovarian cancer	0.00354	0.0238	CbGeAlD
Isradipine—CACNA2D1—lymph node—ovarian cancer	0.00333	0.0223	CbGeAlD
Isradipine—CACNA1D—lymph node—ovarian cancer	0.0031	0.0208	CbGeAlD
Isradipine—CACNA1C—lymph node—ovarian cancer	0.00286	0.0192	CbGeAlD
Isradipine—CYP3A4—female reproductive system—ovarian cancer	0.0018	0.0121	CbGeAlD
Isradipine—Lethargy—Doxorubicin—ovarian cancer	0.00113	0.00161	CcSEcCtD
Isradipine—Leukopenia—Paclitaxel—ovarian cancer	0.00113	0.00161	CcSEcCtD
Isradipine—Rash—Topotecan—ovarian cancer	0.00113	0.00161	CcSEcCtD
Isradipine—Dermatitis—Topotecan—ovarian cancer	0.00113	0.00161	CcSEcCtD
Isradipine—Nisoldipine—ABCB1—ovarian cancer	0.00112	0.204	CrCbGaD
Isradipine—Headache—Topotecan—ovarian cancer	0.00112	0.0016	CcSEcCtD
Isradipine—Palpitations—Paclitaxel—ovarian cancer	0.00111	0.00159	CcSEcCtD
Isradipine—Angiopathy—Docetaxel—ovarian cancer	0.00111	0.00159	CcSEcCtD
Isradipine—Vomiting—Melphalan—ovarian cancer	0.00111	0.00159	CcSEcCtD
Isradipine—Immune system disorder—Docetaxel—ovarian cancer	0.00111	0.00158	CcSEcCtD
Isradipine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00111	0.00158	CcSEcCtD
Isradipine—Pain in extremity—Doxorubicin—ovarian cancer	0.00111	0.00158	CcSEcCtD
Isradipine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00111	0.00158	CcSEcCtD
Isradipine—Liver function test abnormal—Epirubicin—ovarian cancer	0.00111	0.00158	CcSEcCtD
Isradipine—Rash—Melphalan—ovarian cancer	0.0011	0.00157	CcSEcCtD
Isradipine—Dermatitis—Melphalan—ovarian cancer	0.0011	0.00157	CcSEcCtD
Isradipine—Cough—Paclitaxel—ovarian cancer	0.0011	0.00157	CcSEcCtD
Isradipine—Asthenia—Vinorelbine—ovarian cancer	0.0011	0.00157	CcSEcCtD
Isradipine—Pruritus—Vinorelbine—ovarian cancer	0.00108	0.00154	CcSEcCtD
Isradipine—Breast disorder—Epirubicin—ovarian cancer	0.00108	0.00154	CcSEcCtD
Isradipine—Mental disorder—Docetaxel—ovarian cancer	0.00108	0.00153	CcSEcCtD
Isradipine—Chest pain—Paclitaxel—ovarian cancer	0.00107	0.00153	CcSEcCtD
Isradipine—Arthralgia—Paclitaxel—ovarian cancer	0.00107	0.00153	CcSEcCtD
Isradipine—Anxiety—Paclitaxel—ovarian cancer	0.00107	0.00153	CcSEcCtD
Isradipine—Malnutrition—Docetaxel—ovarian cancer	0.00107	0.00152	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00107	0.00152	CcSEcCtD
Isradipine—Nausea—Topotecan—ovarian cancer	0.00106	0.00152	CcSEcCtD
Isradipine—Discomfort—Paclitaxel—ovarian cancer	0.00106	0.00151	CcSEcCtD
Isradipine—Nitrendipine—ABCB1—ovarian cancer	0.00105	0.19	CrCbGaD
Isradipine—Dry mouth—Paclitaxel—ovarian cancer	0.00105	0.0015	CcSEcCtD
Isradipine—Diarrhoea—Vinorelbine—ovarian cancer	0.00105	0.00149	CcSEcCtD
Isradipine—Nausea—Melphalan—ovarian cancer	0.00104	0.00148	CcSEcCtD
Isradipine—Back pain—Docetaxel—ovarian cancer	0.00103	0.00147	CcSEcCtD
Isradipine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00103	0.00147	CcSEcCtD
Isradipine—Oedema—Paclitaxel—ovarian cancer	0.00103	0.00147	CcSEcCtD
Isradipine—Muscle spasms—Docetaxel—ovarian cancer	0.00103	0.00147	CcSEcCtD
Isradipine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00102	0.00146	CcSEcCtD
Isradipine—Shock—Paclitaxel—ovarian cancer	0.00101	0.00144	CcSEcCtD
Isradipine—Dizziness—Vinorelbine—ovarian cancer	0.00101	0.00144	CcSEcCtD
Isradipine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00101	0.00144	CcSEcCtD
Isradipine—Angina pectoris—Epirubicin—ovarian cancer	0.00101	0.00144	CcSEcCtD
Isradipine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00101	0.00144	CcSEcCtD
Isradipine—Tachycardia—Paclitaxel—ovarian cancer	0.001	0.00143	CcSEcCtD
Isradipine—Breast disorder—Doxorubicin—ovarian cancer	0.001	0.00143	CcSEcCtD
Isradipine—Skin disorder—Paclitaxel—ovarian cancer	0.001	0.00143	CcSEcCtD
Isradipine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000995	0.00142	CcSEcCtD
Isradipine—Anaemia—Docetaxel—ovarian cancer	0.000988	0.00141	CcSEcCtD
Isradipine—Vomiting—Vinorelbine—ovarian cancer	0.000973	0.00139	CcSEcCtD
Isradipine—Rash—Vinorelbine—ovarian cancer	0.000965	0.00138	CcSEcCtD
Isradipine—Dermatitis—Vinorelbine—ovarian cancer	0.000964	0.00137	CcSEcCtD
Isradipine—Hypotension—Paclitaxel—ovarian cancer	0.000962	0.00137	CcSEcCtD
Isradipine—Headache—Vinorelbine—ovarian cancer	0.000959	0.00137	CcSEcCtD
Isradipine—Syncope—Docetaxel—ovarian cancer	0.000959	0.00137	CcSEcCtD
Isradipine—Leukopenia—Docetaxel—ovarian cancer	0.000957	0.00136	CcSEcCtD
Isradipine—Pollakiuria—Epirubicin—ovarian cancer	0.000956	0.00136	CcSEcCtD
Isradipine—Palpitations—Docetaxel—ovarian cancer	0.000945	0.00135	CcSEcCtD
Isradipine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000945	0.00135	CcSEcCtD
Isradipine—Weight increased—Epirubicin—ovarian cancer	0.000942	0.00134	CcSEcCtD
Isradipine—Loss of consciousness—Docetaxel—ovarian cancer	0.00094	0.00134	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000938	0.00134	CcSEcCtD
Isradipine—Cough—Docetaxel—ovarian cancer	0.000933	0.00133	CcSEcCtD
Isradipine—Angina pectoris—Doxorubicin—ovarian cancer	0.000933	0.00133	CcSEcCtD
Isradipine—Insomnia—Paclitaxel—ovarian cancer	0.000931	0.00133	CcSEcCtD
Isradipine—Paraesthesia—Paclitaxel—ovarian cancer	0.000925	0.00132	CcSEcCtD
Isradipine—Drowsiness—Epirubicin—ovarian cancer	0.000923	0.00132	CcSEcCtD
Isradipine—Dyspnoea—Paclitaxel—ovarian cancer	0.000918	0.00131	CcSEcCtD
Isradipine—Somnolence—Paclitaxel—ovarian cancer	0.000915	0.0013	CcSEcCtD
Isradipine—Arthralgia—Docetaxel—ovarian cancer	0.00091	0.0013	CcSEcCtD
Isradipine—Chest pain—Docetaxel—ovarian cancer	0.00091	0.0013	CcSEcCtD
Isradipine—Nausea—Vinorelbine—ovarian cancer	0.000909	0.0013	CcSEcCtD
Isradipine—Dyspepsia—Paclitaxel—ovarian cancer	0.000906	0.00129	CcSEcCtD
Isradipine—Amlodipine—ABCB1—ovarian cancer	0.000906	0.164	CrCbGaD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000904	0.00129	CcSEcCtD
Isradipine—Decreased appetite—Paclitaxel—ovarian cancer	0.000895	0.00128	CcSEcCtD
Isradipine—Dry mouth—Docetaxel—ovarian cancer	0.00089	0.00127	CcSEcCtD
Isradipine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000889	0.00127	CcSEcCtD
Isradipine—Fatigue—Paclitaxel—ovarian cancer	0.000888	0.00127	CcSEcCtD
Isradipine—Pollakiuria—Doxorubicin—ovarian cancer	0.000885	0.00126	CcSEcCtD
Isradipine—Constipation—Paclitaxel—ovarian cancer	0.000881	0.00126	CcSEcCtD
Isradipine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000874	0.00125	CcSEcCtD
Isradipine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000873	0.00124	CcSEcCtD
Isradipine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000873	0.00124	CcSEcCtD
Isradipine—Oedema—Docetaxel—ovarian cancer	0.000873	0.00124	CcSEcCtD
Isradipine—Weight increased—Doxorubicin—ovarian cancer	0.000872	0.00124	CcSEcCtD
Isradipine—Shock—Docetaxel—ovarian cancer	0.000859	0.00122	CcSEcCtD
Isradipine—Nervous system disorder—Docetaxel—ovarian cancer	0.000856	0.00122	CcSEcCtD
Isradipine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000855	0.00122	CcSEcCtD
Isradipine—Drowsiness—Doxorubicin—ovarian cancer	0.000854	0.00122	CcSEcCtD
Isradipine—Tachycardia—Docetaxel—ovarian cancer	0.000852	0.00121	CcSEcCtD
Isradipine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000849	0.00121	CcSEcCtD
Isradipine—Skin disorder—Docetaxel—ovarian cancer	0.000848	0.00121	CcSEcCtD
Isradipine—Bradycardia—Epirubicin—ovarian cancer	0.000844	0.0012	CcSEcCtD
Isradipine—Felodipine—ABCB1—ovarian cancer	0.000837	0.152	CrCbGaD
Isradipine—Hepatitis—Epirubicin—ovarian cancer	0.000829	0.00118	CcSEcCtD
Isradipine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000824	0.00118	CcSEcCtD
Isradipine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000818	0.00117	CcSEcCtD
Isradipine—Urticaria—Paclitaxel—ovarian cancer	0.000818	0.00117	CcSEcCtD
Isradipine—Oedema peripheral—Epirubicin—ovarian cancer	0.000816	0.00116	CcSEcCtD
Isradipine—Hypotension—Docetaxel—ovarian cancer	0.000816	0.00116	CcSEcCtD
Isradipine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000814	0.00116	CcSEcCtD
Isradipine—Urethral disorder—Epirubicin—ovarian cancer	0.000812	0.00116	CcSEcCtD
Isradipine—Nifedipine—ABCB1—ovarian cancer	0.00081	0.147	CrCbGaD
Isradipine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000808	0.00115	CcSEcCtD
Isradipine—Visual impairment—Epirubicin—ovarian cancer	0.000799	0.00114	CcSEcCtD
Isradipine—Nicardipine—ABCB1—ovarian cancer	0.000797	0.144	CrCbGaD
Isradipine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000795	0.00113	CcSEcCtD
Isradipine—Insomnia—Docetaxel—ovarian cancer	0.000789	0.00113	CcSEcCtD
Isradipine—Paraesthesia—Docetaxel—ovarian cancer	0.000784	0.00112	CcSEcCtD
Isradipine—Bradycardia—Doxorubicin—ovarian cancer	0.000781	0.00111	CcSEcCtD
Isradipine—Dyspnoea—Docetaxel—ovarian cancer	0.000778	0.00111	CcSEcCtD
Isradipine—Somnolence—Docetaxel—ovarian cancer	0.000776	0.00111	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—ovarian cancer	0.000774	0.0011	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—ovarian cancer	0.000769	0.0011	CcSEcCtD
Isradipine—Flushing—Epirubicin—ovarian cancer	0.000769	0.0011	CcSEcCtD
Isradipine—Dyspepsia—Docetaxel—ovarian cancer	0.000768	0.0011	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—ovarian cancer	0.000767	0.00109	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000763	0.00109	CcSEcCtD
Isradipine—Decreased appetite—Docetaxel—ovarian cancer	0.000759	0.00108	CcSEcCtD
Isradipine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000757	0.00108	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000755	0.00108	CcSEcCtD
Isradipine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000753	0.00107	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000753	0.00107	CcSEcCtD
Isradipine—Fatigue—Docetaxel—ovarian cancer	0.000752	0.00107	CcSEcCtD
Isradipine—Angiopathy—Epirubicin—ovarian cancer	0.000752	0.00107	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—ovarian cancer	0.000752	0.00107	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—ovarian cancer	0.000748	0.00107	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000747	0.00106	CcSEcCtD
Isradipine—Constipation—Docetaxel—ovarian cancer	0.000746	0.00106	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—ovarian cancer	0.000739	0.00105	CcSEcCtD
Isradipine—Asthenia—Paclitaxel—ovarian cancer	0.000739	0.00105	CcSEcCtD
Isradipine—Pruritus—Paclitaxel—ovarian cancer	0.000729	0.00104	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—ovarian cancer	0.000726	0.00103	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—ovarian cancer	0.000721	0.00103	CcSEcCtD
Isradipine—Feeling abnormal—Docetaxel—ovarian cancer	0.000719	0.00103	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—ovarian cancer	0.000716	0.00102	CcSEcCtD
Isradipine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000712	0.00101	CcSEcCtD
Isradipine—Flushing—Doxorubicin—ovarian cancer	0.000712	0.00101	CcSEcCtD
Isradipine—Tension—Epirubicin—ovarian cancer	0.000708	0.00101	CcSEcCtD
Isradipine—Diarrhoea—Paclitaxel—ovarian cancer	0.000705	0.001	CcSEcCtD
Isradipine—Nervousness—Epirubicin—ovarian cancer	0.000701	0.000999	CcSEcCtD
Isradipine—Back pain—Epirubicin—ovarian cancer	0.000698	0.000995	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—ovarian cancer	0.000696	0.000991	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—ovarian cancer	0.000693	0.000988	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—ovarian cancer	0.000693	0.000987	CcSEcCtD
Isradipine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000691	0.000985	CcSEcCtD
Isradipine—Dizziness—Paclitaxel—ovarian cancer	0.000681	0.000971	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—ovarian cancer	0.00068	0.000969	CcSEcCtD
Isradipine—Mental disorder—Doxorubicin—ovarian cancer	0.000672	0.000957	CcSEcCtD
Isradipine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000669	0.000954	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—ovarian cancer	0.000667	0.000951	CcSEcCtD
Isradipine—Anaemia—Epirubicin—ovarian cancer	0.000667	0.00095	CcSEcCtD
Isradipine—Tension—Doxorubicin—ovarian cancer	0.000655	0.000934	CcSEcCtD
Isradipine—Vomiting—Paclitaxel—ovarian cancer	0.000655	0.000933	CcSEcCtD
Isradipine—Malaise—Epirubicin—ovarian cancer	0.00065	0.000927	CcSEcCtD
Isradipine—Rash—Paclitaxel—ovarian cancer	0.000649	0.000925	CcSEcCtD
Isradipine—Dermatitis—Paclitaxel—ovarian cancer	0.000649	0.000925	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—ovarian cancer	0.000648	0.000924	CcSEcCtD
Isradipine—Syncope—Epirubicin—ovarian cancer	0.000647	0.000922	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—ovarian cancer	0.000646	0.00092	CcSEcCtD
Isradipine—Back pain—Doxorubicin—ovarian cancer	0.000646	0.00092	CcSEcCtD
Isradipine—Headache—Paclitaxel—ovarian cancer	0.000645	0.000919	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—ovarian cancer	0.000642	0.000915	CcSEcCtD
Isradipine—Palpitations—Epirubicin—ovarian cancer	0.000637	0.000909	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—ovarian cancer	0.000634	0.000904	CcSEcCtD
Isradipine—Cough—Epirubicin—ovarian cancer	0.000629	0.000897	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—ovarian cancer	0.000629	0.000897	CcSEcCtD
Isradipine—Asthenia—Docetaxel—ovarian cancer	0.000626	0.000893	CcSEcCtD
Isradipine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000619	0.000883	CcSEcCtD
Isradipine—Pruritus—Docetaxel—ovarian cancer	0.000617	0.00088	CcSEcCtD
Isradipine—Anaemia—Doxorubicin—ovarian cancer	0.000617	0.000879	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—ovarian cancer	0.000614	0.000875	CcSEcCtD
Isradipine—Chest pain—Epirubicin—ovarian cancer	0.000614	0.000875	CcSEcCtD
Isradipine—Anxiety—Epirubicin—ovarian cancer	0.000612	0.000872	CcSEcCtD
Isradipine—Nausea—Paclitaxel—ovarian cancer	0.000612	0.000872	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00061	0.000869	CcSEcCtD
Isradipine—Discomfort—Epirubicin—ovarian cancer	0.000607	0.000865	CcSEcCtD
Isradipine—Malaise—Doxorubicin—ovarian cancer	0.000602	0.000858	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—ovarian cancer	0.000601	0.000856	CcSEcCtD
Isradipine—Syncope—Doxorubicin—ovarian cancer	0.000599	0.000853	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—ovarian cancer	0.000597	0.000852	CcSEcCtD
Isradipine—Diarrhoea—Docetaxel—ovarian cancer	0.000597	0.000851	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—ovarian cancer	0.00059	0.000841	CcSEcCtD
Isradipine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000589	0.000839	CcSEcCtD
Isradipine—Oedema—Epirubicin—ovarian cancer	0.000589	0.000839	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000587	0.000836	CcSEcCtD
Isradipine—Cough—Doxorubicin—ovarian cancer	0.000582	0.00083	CcSEcCtD
Isradipine—Shock—Epirubicin—ovarian cancer	0.000579	0.000826	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—ovarian cancer	0.000577	0.000823	CcSEcCtD
Isradipine—Dizziness—Docetaxel—ovarian cancer	0.000577	0.000823	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000576	0.000822	CcSEcCtD
Isradipine—Tachycardia—Epirubicin—ovarian cancer	0.000575	0.000819	CcSEcCtD
Isradipine—Skin disorder—Epirubicin—ovarian cancer	0.000572	0.000815	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000569	0.000811	CcSEcCtD
Isradipine—Chest pain—Doxorubicin—ovarian cancer	0.000568	0.00081	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—ovarian cancer	0.000568	0.00081	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—ovarian cancer	0.000566	0.000807	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000564	0.000804	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—ovarian cancer	0.000561	0.0008	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—ovarian cancer	0.000556	0.000792	CcSEcCtD
Isradipine—Vomiting—Docetaxel—ovarian cancer	0.000555	0.000791	CcSEcCtD
Isradipine—Rash—Docetaxel—ovarian cancer	0.00055	0.000784	CcSEcCtD
Isradipine—Hypotension—Epirubicin—ovarian cancer	0.00055	0.000784	CcSEcCtD
Isradipine—Dermatitis—Docetaxel—ovarian cancer	0.00055	0.000784	CcSEcCtD
Isradipine—Headache—Docetaxel—ovarian cancer	0.000547	0.000779	CcSEcCtD
Isradipine—Oedema—Doxorubicin—ovarian cancer	0.000545	0.000776	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000545	0.000776	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000536	0.000764	CcSEcCtD
Isradipine—Shock—Doxorubicin—ovarian cancer	0.000536	0.000764	CcSEcCtD
Isradipine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000534	0.000761	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000533	0.00076	CcSEcCtD
Isradipine—Insomnia—Epirubicin—ovarian cancer	0.000532	0.000759	CcSEcCtD
Isradipine—Tachycardia—Doxorubicin—ovarian cancer	0.000532	0.000758	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—ovarian cancer	0.000529	0.000754	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—ovarian cancer	0.000529	0.000753	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000527	0.000751	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—ovarian cancer	0.000525	0.000748	CcSEcCtD
Isradipine—Somnolence—Epirubicin—ovarian cancer	0.000523	0.000746	CcSEcCtD
Isradipine—Nausea—Docetaxel—ovarian cancer	0.000518	0.000739	CcSEcCtD
Isradipine—Dyspepsia—Epirubicin—ovarian cancer	0.000518	0.000739	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—ovarian cancer	0.000512	0.000729	CcSEcCtD
Isradipine—Hypotension—Doxorubicin—ovarian cancer	0.000509	0.000725	CcSEcCtD
Isradipine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000508	0.000724	CcSEcCtD
Isradipine—Fatigue—Epirubicin—ovarian cancer	0.000508	0.000723	CcSEcCtD
Isradipine—Constipation—Epirubicin—ovarian cancer	0.000503	0.000718	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000496	0.000707	CcSEcCtD
Isradipine—Insomnia—Doxorubicin—ovarian cancer	0.000493	0.000702	CcSEcCtD
Isradipine—Paraesthesia—Doxorubicin—ovarian cancer	0.000489	0.000697	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—ovarian cancer	0.000486	0.000692	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—ovarian cancer	0.000485	0.000691	CcSEcCtD
Isradipine—Somnolence—Doxorubicin—ovarian cancer	0.000484	0.00069	CcSEcCtD
Isradipine—Dyspepsia—Doxorubicin—ovarian cancer	0.000479	0.000683	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—ovarian cancer	0.000474	0.000675	CcSEcCtD
Isradipine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00047	0.00067	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—ovarian cancer	0.00047	0.000669	CcSEcCtD
Isradipine—Urticaria—Epirubicin—ovarian cancer	0.000468	0.000667	CcSEcCtD
Isradipine—Constipation—Doxorubicin—ovarian cancer	0.000466	0.000664	CcSEcCtD
Isradipine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000449	0.00064	CcSEcCtD
Isradipine—Urticaria—Doxorubicin—ovarian cancer	0.000433	0.000617	CcSEcCtD
Isradipine—Asthenia—Epirubicin—ovarian cancer	0.000422	0.000602	CcSEcCtD
Isradipine—Pruritus—Epirubicin—ovarian cancer	0.000416	0.000594	CcSEcCtD
Isradipine—Diarrhoea—Epirubicin—ovarian cancer	0.000403	0.000574	CcSEcCtD
Isradipine—Asthenia—Doxorubicin—ovarian cancer	0.000391	0.000557	CcSEcCtD
Isradipine—Dizziness—Epirubicin—ovarian cancer	0.000389	0.000555	CcSEcCtD
Isradipine—Pruritus—Doxorubicin—ovarian cancer	0.000385	0.000549	CcSEcCtD
Isradipine—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000378	0.00263	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—ovarian cancer	0.000376	0.00261	CbGpPWpGaD
Isradipine—Vomiting—Epirubicin—ovarian cancer	0.000374	0.000534	CcSEcCtD
Isradipine—Diarrhoea—Doxorubicin—ovarian cancer	0.000373	0.000531	CcSEcCtD
Isradipine—Rash—Epirubicin—ovarian cancer	0.000371	0.000529	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—ovarian cancer	0.000371	0.000529	CcSEcCtD
Isradipine—Headache—Epirubicin—ovarian cancer	0.000369	0.000526	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—TP53—ovarian cancer	0.000364	0.00253	CbGpPWpGaD
Isradipine—Dizziness—Doxorubicin—ovarian cancer	0.00036	0.000513	CcSEcCtD
Isradipine—Nausea—Epirubicin—ovarian cancer	0.00035	0.000498	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—ovarian cancer	0.000346	0.000494	CcSEcCtD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—ovarian cancer	0.000345	0.0024	CbGpPWpGaD
Isradipine—Rash—Doxorubicin—ovarian cancer	0.000343	0.00049	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—ovarian cancer	0.000343	0.000489	CcSEcCtD
Isradipine—Headache—Doxorubicin—ovarian cancer	0.000341	0.000486	CcSEcCtD
Isradipine—CACNA1S—Axon guidance—MET—ovarian cancer	0.000341	0.00237	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MMP2—ovarian cancer	0.000335	0.00233	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—IL6ST—ovarian cancer	0.000334	0.00232	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—ovarian cancer	0.00033	0.00229	CbGpPWpGaD
Isradipine—Nausea—Doxorubicin—ovarian cancer	0.000324	0.000461	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—TP53—ovarian cancer	0.00032	0.00222	CbGpPWpGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000318	0.00221	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000306	0.00213	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYTB—ovarian cancer	0.000302	0.0021	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000302	0.0021	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—ERBB2—ovarian cancer	0.000294	0.00204	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MET—ovarian cancer	0.000292	0.00203	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MET—ovarian cancer	0.000287	0.00199	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6ST—ovarian cancer	0.000286	0.00199	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYTB—ovarian cancer	0.000286	0.00199	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MMP2—ovarian cancer	0.000284	0.00198	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6ST—ovarian cancer	0.000281	0.00195	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MET—ovarian cancer	0.000277	0.00192	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6ST—ovarian cancer	0.000271	0.00188	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PPP1CC—ovarian cancer	0.000264	0.00184	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—BRIP1—ovarian cancer	0.000264	0.00184	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—YAP1—ovarian cancer	0.000259	0.0018	CbGpPWpGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000255	0.00177	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MMP9—ovarian cancer	0.000252	0.00175	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYTB—ovarian cancer	0.000251	0.00175	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PPP1CC—ovarian cancer	0.00025	0.00174	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—BRIP1—ovarian cancer	0.00025	0.00174	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—ERBB2—ovarian cancer	0.000249	0.00173	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000248	0.00172	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MMP2—ovarian cancer	0.000244	0.00169	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—MAPK1—ovarian cancer	0.000244	0.00169	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MET—ovarian cancer	0.000243	0.00169	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MET—ovarian cancer	0.000243	0.00169	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MMP2—ovarian cancer	0.000239	0.00166	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6ST—ovarian cancer	0.000238	0.00166	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6ST—ovarian cancer	0.000238	0.00166	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MMP2—ovarian cancer	0.000231	0.0016	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—VEGFA—ovarian cancer	0.000226	0.00157	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—NRAS—ovarian cancer	0.000223	0.00155	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PPP1CC—ovarian cancer	0.00022	0.00153	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—BRIP1—ovarian cancer	0.00022	0.00153	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000218	0.00151	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MAPK3—ovarian cancer	0.000214	0.00149	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MMP9—ovarian cancer	0.000214	0.00149	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—ERBB2—ovarian cancer	0.000214	0.00148	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—FASN—ovarian cancer	0.000211	0.00146	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—ERBB2—ovarian cancer	0.00021	0.00146	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MET—ovarian cancer	0.000209	0.00145	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—SLC5A5—ovarian cancer	0.000207	0.00144	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6ST—ovarian cancer	0.000204	0.00142	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MAPK1—ovarian cancer	0.000204	0.00142	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—EGFR—ovarian cancer	0.000204	0.00141	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP2—ovarian cancer	0.000203	0.00141	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP2—ovarian cancer	0.000203	0.00141	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—ERBB2—ovarian cancer	0.000202	0.00141	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—SLC2A1—ovarian cancer	0.0002	0.00139	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MET—ovarian cancer	0.000198	0.00137	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—HRAS—ovarian cancer	0.000196	0.00136	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6ST—ovarian cancer	0.000194	0.00134	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—KRAS—ovarian cancer	0.000192	0.00134	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP1B1—ovarian cancer	0.000192	0.00133	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—VEGFA—ovarian cancer	0.000192	0.00133	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—NRAS—ovarian cancer	0.00019	0.00132	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CTNNB1—ovarian cancer	0.000183	0.00127	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MMP9—ovarian cancer	0.000183	0.00127	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MAPK3—ovarian cancer	0.000182	0.00126	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MMP9—ovarian cancer	0.00018	0.00125	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ERBB2—ovarian cancer	0.000178	0.00124	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—ERBB2—ovarian cancer	0.000178	0.00124	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—YAP1—ovarian cancer	0.000177	0.00123	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000175	0.00122	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP2—ovarian cancer	0.000174	0.00121	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MET—ovarian cancer	0.000174	0.00121	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MMP9—ovarian cancer	0.000174	0.00121	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MAPK1—ovarian cancer	0.000173	0.0012	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—EGFR—ovarian cancer	0.000173	0.0012	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PPP2R1A—ovarian cancer	0.00017	0.00118	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6ST—ovarian cancer	0.00017	0.00118	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—YAP1—ovarian cancer	0.000168	0.00117	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—MAPK1—ovarian cancer	0.000167	0.00116	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP2—ovarian cancer	0.000165	0.00115	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—VEGFA—ovarian cancer	0.000165	0.00114	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—HRAS—ovarian cancer	0.000163	0.00114	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—KRAS—ovarian cancer	0.000163	0.00113	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—NRAS—ovarian cancer	0.000163	0.00113	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—VEGFA—ovarian cancer	0.000161	0.00112	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—STAT3—ovarian cancer	0.00016	0.00111	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NRAS—ovarian cancer	0.000159	0.00111	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ABCB1—ovarian cancer	0.000158	0.0011	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—IL6—ovarian cancer	0.000156	0.00109	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—VEGFA—ovarian cancer	0.000156	0.00108	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MAPK3—ovarian cancer	0.000156	0.00108	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CTNNB1—ovarian cancer	0.000156	0.00108	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—TYMS—ovarian cancer	0.000155	0.00108	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—NRAS—ovarian cancer	0.000154	0.00107	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MAPK3—ovarian cancer	0.000153	0.00106	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP9—ovarian cancer	0.000153	0.00106	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP9—ovarian cancer	0.000152	0.00106	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—ERBB2—ovarian cancer	0.000152	0.00106	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MAPK1—ovarian cancer	0.000148	0.00103	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—EGFR—ovarian cancer	0.000148	0.00103	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—YAP1—ovarian cancer	0.000147	0.00102	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MAPK3—ovarian cancer	0.000147	0.00102	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MAPK1—ovarian cancer	0.000145	0.00101	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EGFR—ovarian cancer	0.000145	0.00101	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP2—ovarian cancer	0.000145	0.00101	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—FASN—ovarian cancer	0.000144	0.001	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—ERBB2—ovarian cancer	0.000144	0.001	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SLC5A5—ovarian cancer	0.000142	0.000987	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MAPK1—ovarian cancer	0.00014	0.000975	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—EGFR—ovarian cancer	0.00014	0.000975	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—KRAS—ovarian cancer	0.00014	0.000972	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—HRAS—ovarian cancer	0.000139	0.000964	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—KRAS—ovarian cancer	0.000137	0.000954	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SLC2A1—ovarian cancer	0.000137	0.000954	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—VEGFA—ovarian cancer	0.000137	0.000952	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—VEGFA—ovarian cancer	0.000137	0.000952	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—FASN—ovarian cancer	0.000137	0.000951	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—STAT3—ovarian cancer	0.000136	0.000943	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—NRAS—ovarian cancer	0.000135	0.00094	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—NRAS—ovarian cancer	0.000135	0.00094	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SLC5A5—ovarian cancer	0.000135	0.000935	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—HRAS—ovarian cancer	0.000134	0.000931	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CTNNB1—ovarian cancer	0.000133	0.000927	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—IL6—ovarian cancer	0.000133	0.000923	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—KRAS—ovarian cancer	0.000132	0.000921	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000132	0.000915	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP1B1—ovarian cancer	0.000132	0.000914	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP9—ovarian cancer	0.000131	0.000909	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SLC2A1—ovarian cancer	0.00013	0.000903	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00013	0.000903	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MAPK3—ovarian cancer	0.00013	0.0009	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MAPK3—ovarian cancer	0.00013	0.0009	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ERBB2—ovarian cancer	0.000127	0.000882	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CTNNB1—ovarian cancer	0.000126	0.000878	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CAV1—ovarian cancer	0.000125	0.000869	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1B1—ovarian cancer	0.000125	0.000866	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP9—ovarian cancer	0.000124	0.000861	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MAPK1—ovarian cancer	0.000123	0.000857	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EGFR—ovarian cancer	0.000123	0.000857	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MAPK1—ovarian cancer	0.000123	0.000857	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—EGFR—ovarian cancer	0.000123	0.000856	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—FASN—ovarian cancer	0.00012	0.000835	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—HRAS—ovarian cancer	0.000119	0.000826	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC5A5—ovarian cancer	0.000118	0.000822	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—VEGFA—ovarian cancer	0.000117	0.000816	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PPP2R1A—ovarian cancer	0.000117	0.000811	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—ovarian cancer	0.000117	0.000811	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KRAS—ovarian cancer	0.000116	0.000809	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KRAS—ovarian cancer	0.000116	0.000809	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—STAT3—ovarian cancer	0.000116	0.000808	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NRAS—ovarian cancer	0.000116	0.000806	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC2A1—ovarian cancer	0.000114	0.000794	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CG—ovarian cancer	0.000114	0.000792	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6—ovarian cancer	0.000114	0.000791	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—ovarian cancer	0.000113	0.000783	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6—ovarian cancer	0.000112	0.000776	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—VEGFA—ovarian cancer	0.000111	0.000773	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK3—ovarian cancer	0.000111	0.000772	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CTNNB1—ovarian cancer	0.000111	0.000771	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PPP2R1A—ovarian cancer	0.00011	0.000768	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—STAT3—ovarian cancer	0.00011	0.000765	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NRAS—ovarian cancer	0.00011	0.000763	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1B1—ovarian cancer	0.000109	0.000761	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP9—ovarian cancer	0.000109	0.000756	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ABCB1—ovarian cancer	0.000108	0.000753	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6—ovarian cancer	0.000108	0.000749	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—TYMS—ovarian cancer	0.000106	0.000739	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK1—ovarian cancer	0.000106	0.000735	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EGFR—ovarian cancer	0.000106	0.000734	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK3—ovarian cancer	0.000105	0.000731	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—AKT1—ovarian cancer	0.000103	0.000716	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ABCB1—ovarian cancer	0.000103	0.000713	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—TYMS—ovarian cancer	0.000101	0.0007	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CD—ovarian cancer	0.0001	0.000696	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK1—ovarian cancer	0.0001	0.000696	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EGFR—ovarian cancer	0.0001	0.000696	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KRAS—ovarian cancer	9.98e-05	0.000694	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—ovarian cancer	9.9e-05	0.000688	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—ovarian cancer	9.89e-05	0.000688	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—VEGFA—ovarian cancer	9.77e-05	0.000679	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PPP2R1A—ovarian cancer	9.71e-05	0.000675	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—STAT3—ovarian cancer	9.67e-05	0.000672	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NRAS—ovarian cancer	9.65e-05	0.000671	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6—ovarian cancer	9.47e-05	0.000658	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6—ovarian cancer	9.47e-05	0.000658	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KRAS—ovarian cancer	9.45e-05	0.000657	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK3—ovarian cancer	9.24e-05	0.000642	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ABCB1—ovarian cancer	9.01e-05	0.000627	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—TYMS—ovarian cancer	8.85e-05	0.000615	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK1—ovarian cancer	8.79e-05	0.000611	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EGFR—ovarian cancer	8.79e-05	0.000611	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—AKT1—ovarian cancer	8.74e-05	0.000607	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CB—ovarian cancer	8.73e-05	0.000607	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CAV1—ovarian cancer	8.57e-05	0.000596	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—ovarian cancer	8.48e-05	0.00059	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KRAS—ovarian cancer	8.31e-05	0.000577	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6—ovarian cancer	8.12e-05	0.000564	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CAV1—ovarian cancer	8.12e-05	0.000564	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—ovarian cancer	8.04e-05	0.000558	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NME2—ovarian cancer	8.03e-05	0.000558	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CG—ovarian cancer	7.81e-05	0.000543	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6—ovarian cancer	7.69e-05	0.000535	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTEN—ovarian cancer	7.54e-05	0.000524	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—AKT1—ovarian cancer	7.49e-05	0.000521	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CG—ovarian cancer	7.39e-05	0.000514	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CAV1—ovarian cancer	7.13e-05	0.000496	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—AKT1—ovarian cancer	7.09e-05	0.000493	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—ovarian cancer	7.06e-05	0.000491	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CD—ovarian cancer	6.86e-05	0.000477	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6—ovarian cancer	6.76e-05	0.00047	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CD—ovarian cancer	6.5e-05	0.000452	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CG—ovarian cancer	6.5e-05	0.000452	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—AKT1—ovarian cancer	6.23e-05	0.000433	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CB—ovarian cancer	5.98e-05	0.000416	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CD—ovarian cancer	5.71e-05	0.000397	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CB—ovarian cancer	5.67e-05	0.000394	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CA—ovarian cancer	5.32e-05	0.00037	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYTB—ovarian cancer	5.18e-05	0.00036	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTEN—ovarian cancer	5.17e-05	0.000359	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CB—ovarian cancer	4.98e-05	0.000346	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTEN—ovarian cancer	4.9e-05	0.00034	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.52e-05	0.000314	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.52e-05	0.000314	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKT1—ovarian cancer	4.35e-05	0.000302	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTEN—ovarian cancer	4.3e-05	0.000299	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CA—ovarian cancer	3.65e-05	0.000254	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CA—ovarian cancer	3.45e-05	0.00024	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CA—ovarian cancer	3.04e-05	0.000211	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—YAP1—ovarian cancer	3.03e-05	0.000211	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKT1—ovarian cancer	2.98e-05	0.000207	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKT1—ovarian cancer	2.82e-05	0.000196	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKT1—ovarian cancer	2.48e-05	0.000172	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—FASN—ovarian cancer	2.47e-05	0.000172	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.43e-05	0.000169	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.35e-05	0.000163	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.25e-05	0.000157	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2e-05	0.000139	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.85e-05	0.000129	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TYMS—ovarian cancer	1.82e-05	0.000127	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CAV1—ovarian cancer	1.47e-05	0.000102	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.34e-05	9.29e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.18e-05	8.17e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.02e-05	7.12e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTEN—ovarian cancer	8.85e-06	6.15e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	6.25e-06	4.34e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKT1—ovarian cancer	5.1e-06	3.55e-05	CbGpPWpGaD
